DMKPQ — DMK Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$6.66m
- $4.76m
Annual cashflow statement for DMK Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39 | -29.3 | -49.4 | -45.8 | -26.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 10.2 | 7.09 | 19.8 | 17.4 | 0.427 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.54 | -0.616 | 5.13 | -10.8 | -1.34 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -32.7 | -19.9 | -20.9 | -37.8 | -25.9 |
| Capital Expenditures | -3.54 | -2.87 | -0.946 | -1.22 | -0.68 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | 1.51 | 4.16 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.54 | -2.87 | -0.946 | 0.283 | 3.48 |
| Financing Cash Flow Items | — | — | -1.44 | -5.43 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 37.1 | 12.3 | 19.9 | 53.9 | 0.285 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.939 | -10.5 | -1.96 | 16.4 | -22.1 |